Madrid, Spain

Maria Jp De Vega

This inventor holds 1 USPTO granted patent. Top assignee: Basf Aktiengesellschaft. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Jp De Vega. Retrieved from https://idiyas.com/inventor/maria-jp-de-vega

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Jp De Vega: Innovator in Cancer Treatment

Introduction

Maria Jp De Vega is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to improving healthcare.

Latest Patents

Maria holds a patent for "Bis-naphthalimides for the treatment of cancer." This patent discloses compounds and pharmaceutical compositions that can be utilized in the treatment of cancer. The compounds are characterized by a specific formula, wherein various components are identified in the specification. This groundbreaking work has the potential to make a substantial impact on cancer therapies.

Career Highlights

Throughout her career, Maria has been associated with BASF Aktiengesellschaft, a leading company in the chemical and pharmaceutical industry. Her role at BASF has allowed her to collaborate with other talented professionals and contribute to innovative research and development projects.

Collaborations

Maria has worked alongside notable colleagues, including Gerhard Keilhauer and Cynthia A Romerdahl. These collaborations have enriched her research and have been instrumental in advancing her work in cancer treatment.

Conclusion

Maria Jp De Vega is a remarkable inventor whose contributions to cancer treatment through her patented compounds are noteworthy. Her dedication to innovation and collaboration in the pharmaceutical field continues to inspire advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…